Evolent Health Inc. (NYSE:EVH) was up 1.9% on Friday . The company traded as high as $24.76 and last traded at $24.75, with a volume of 151,836 shares changing hands. The stock had previously closed at $24.30.

A number of equities research analysts have weighed in on EVH shares. Canaccord Genuity reaffirmed a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a report on Wednesday, July 13th. Leerink Swann reaffirmed a “buy” rating and set a $20.00 price objective on shares of Evolent Health in a report on Monday, May 16th. Zacks Investment Research raised Evolent Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th. Jefferies Group began coverage on Evolent Health in a report on Tuesday, July 26th. They issued a “buy” rating and a $28.00 target price on the stock. Finally, FBR & Co boosted their target price on Evolent Health from $24.00 to $26.00 and gave the stock an “outperform” rating in a report on Friday, August 5th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $22.50.

The firm has a 50-day moving average of $23.69 and a 200-day moving average of $15.39. The company’s market capitalization is $1.50 billion.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.16) by $0.04. During the same period in the prior year, the company earned ($0.95) earnings per share. The company earned $56.50 million during the quarter, compared to the consensus estimate of $51.96 million. The firm’s revenue was up 443.3% compared to the same quarter last year. On average, equities analysts expect that Evolent Health Inc. will post ($0.54) earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Evolent Health stock. Wells Fargo & Company MN increased its stake in shares of Evolent Health Inc. (NYSE:EVH) by 22.0% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 808,909 shares of the company’s stock after buying an additional 145,685 shares during the period. Wells Fargo & Company MN owned approximately 1.37% of Evolent Health worth $9,796,000 as of its most recent filing with the SEC.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.